Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Novel Dual E-Selectin-CXCR4 Inhibitors Mobilize Human Acute Myeloid Leukemia (AML) Cells in the NODscid IL2Rγc−/− Xenograft and Confer Susceptibility to Cytarabine

Sylvia Chien, Xin Zhao, MD, John T. Patton, PhD, Theodore Smith, Arun Sarkar, PhD, John L. Magnani, Frederick R. Appelbaum, MD, Pamela S Becker, MD, PhD

Blood (2011) 118 (21): 579.

https://doi.org/10.1182/blood.V118.21.579.579

Published: 2011

Journal Articles

Selectin Inhibition Disrupts Multiple Myeloma Cells Interaction with the Bone Marrow Microenvironment and Sensitizes Them to Therapy

Abdel Kareem A. Azab, PhD, BSPharm, Phong Quang, Feda Azab, John Magnani, John Patton, Theodore Smith, Arun Sarkar, Patricia Maiso, Hai T Ngo, Aldo M. Roccaro, MD, PhD, Antonio Sacco, Yang Liu, PhD, Yong Zhang, PhD, Brittany Morgan, Kenneth C. Anderson, Andrew L. Kung, MD, PhD, Ruben Carrasco, MD, PhD, Irene M. Ghobrial, MD

Blood (2010) 116 (21): 453.

https://doi.org/10.1182/blood.V116.21.453.453

Published: 2010

Journal Articles

Role of Selectins in the Pathogenesis of Multiple Myeloma.

Abdel Kareem Azab, Bpharm, PhD, Phong Quang, Feda Azab, BPharm, Costas M Pitsillides, John T Patton, Theodore Smith, Arun Sarkar, Judith M. Runnels, PhD, Aldo M. Roccaro, MD, PhD, Antonio Sacco, Hai T. Ngo, Molly R Melhem, Patricia Maiso, PhD, Kenneth C. Anderson, MD, Charles P. Lin, PhD, John L. Magnani, Irene M. Ghobrial, M.D.

Blood (2009) 114 (22): 951.

https://doi.org/10.1182/blood.V114.22.951.951

Published: 2009

Journal Articles

Absence or Blockage of E-Selectin-Mediated Cell Adhesion Delays Hematopoietic Stem Cell (HSC) Turn-Over and Enhances Chemoresistance.

Ingrid G Winkler, PhD, Valerie Barbier, Bianca Nowlan, Theodore Smith, John T Patton, John L. Magnani, Jean-Pierre Levesque, PhD

Blood (2009) 114 (22): 564.

https://doi.org/10.1182/blood.V114.22.564.564

Published: 2009

Journal Articles

Pan-Selectin Inhibitor GMI-1070 Blocks Cell Adhesion of Acute Myelogenous Leukemia Cell Lines

John T Patton, Theodore Smith, Leonard D. Shultz, John L. Magnani

Blood (2008) 112 (11): 4039.

https://doi.org/10.1182/blood.V112.11.4039.4039

Published: 2008

NARROW

Novel Dual E-Selectin-CXCR4 Inhibitors Mobilize Human Acute Myeloid Leukemia (AML) Cells in the NODscid IL2Rγc−/− Xenograft and Confer Susceptibility to Cytarabine

Selectin Inhibition Disrupts Multiple Myeloma Cells Interaction with the Bone Marrow Microenvironment and Sensitizes Them to Therapy

Role of Selectins in the Pathogenesis of Multiple Myeloma.

Absence or Blockage of E-Selectin-Mediated Cell Adhesion Delays Hematopoietic Stem Cell (HSC) Turn-Over and Enhances Chemoresistance.

Pan-Selectin Inhibitor GMI-1070 Blocks Cell Adhesion of Acute Myelogenous Leukemia Cell Lines

Email alerts

ASH Publications

American Society of Hematology

Novel Dual E-Selectin-CXCR4 Inhibitors Mobilize Human Acute Myeloid Leukemia (AML) Cells in the NODscid IL2Rγc−/− Xenograft and Confer Susceptibility to Cytarabine

Selectin Inhibition Disrupts Multiple Myeloma Cells Interaction with the Bone Marrow Microenvironment and Sensitizes Them to Therapy

Role of Selectins in the Pathogenesis of Multiple Myeloma.

Absence or Blockage of E-Selectin-Mediated Cell Adhesion Delays Hematopoietic Stem Cell (HSC) Turn-Over and Enhances Chemoresistance.

Pan-Selectin Inhibitor GMI-1070 Blocks Cell Adhesion of Acute Myelogenous Leukemia Cell Lines

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only